Horizontal bar chart showing total announced deal value since the start of 2024 among six patent-exposed pharma companies. Merck leads at $30.9 billion, followed by Eli Lilly at $27.2 billion, AbbVie at $22.3 billion, J&J at $20.4 billion, Sanofi at $16.1 billion and AstraZeneca at $6.8 billion.